The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in myelodysplastic syndromes and its prognostic significance. European Journal of Histochemistry, [S. l.], v. 49, n. 1, p. 27–32, 2009. DOI: 10.4081/923. Disponível em: https://www.ejh.it/ejh/article/view/923. Acesso em: 1 jun. 2025.